Squarepoint Ops LLC Deciphera Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $519,646 - $624,514	-39,130 Reduced 25.31%	115,475 $1.63 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $1.17 Million - $1.81 Million	81,859 Added 112.53%	154,605 $2.39 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $165,072 - $211,648	11,116 Added 18.04%	72,746 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $762,979 - $1.25 Million	61,630 New	61,630 $1.14 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $167,569 - $257,148	-18,394 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $415,896 - $672,577	-60,538 Reduced 76.7%	18,394 $171,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $504,673 - $2.43 Million	65,542 Added 489.48%	78,932 $771,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $88,588 - $124,378	-3,348 Reduced 20.0%	13,390 $455,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $25,300 - $37,065	-773 Reduced 4.41%	16,738 $613,000
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $180,058 - $252,902	4,458 Added 34.15%	17,511 $785,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $200,815 - $256,712	3,879 Added 42.28%	13,053 $745,000
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $401,821 - $533,559	9,174 New	9,174 $471,000
Q2 2019 Aug 14, 2019	SELL	$21.05 - $26.21 $1.01 Million - $1.26 Million	-47,971 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $178,932 - $256,050	8,665 Added 22.04%	47,971 $1.11 Million
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $115,014 - $217,851	6,028 Added 18.11%	39,306 $825,000
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $175,268 - $219,804	5,221 Added 18.61%	33,278 $1.29 Million
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $562,823 - $1.26 Million	28,057 New	28,057 $1.1 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account